金龙固本合剂治疗支气管哮喘缓解期113例

王祺; 郭振武; 崔英海; 姚明; 李国信; 于雪峰

doi:10.11653/syfj2014030180

您当前的位置：

首页 >

文章列表页 >

金龙固本合剂治疗支气管哮喘缓解期113例

更新时间：2024-01-04

- 金龙固本合剂治疗支气管哮喘缓解期113例
- Observation of Curative Effect of Jinlong Guben Mixture on Treating Asthma in Remission Stage in 113 Cases
- 中国实验方剂学杂志 2014年20卷第3期页码：180-182
- 作者机构：
- 作者简介：
- 基金信息：
  
  中医药行业科研专项项目（200807034）
- DOI：10.11653/syfj2014030180
  中图分类号：
- 纸质出版日期：2014
- 稿件说明：
移动端阅览
王祺, 郭振武, 崔英海, 等. 金龙固本合剂治疗支气管哮喘缓解期113例[J]. 中国实验方剂学杂志, 2014,20(3):180-182.

WANG Qi, GUO Zhen-wu, CUI Ying-hai, et al. Observation of Curative Effect of Jinlong Guben Mixture on Treating Asthma in Remission Stage in 113 Cases[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(3): 180-182.
王祺, 郭振武, 崔英海, 等. 金龙固本合剂治疗支气管哮喘缓解期113例[J]. 中国实验方剂学杂志, 2014,20(3):180-182. DOI： 10.11653/syfj2014030180.

WANG Qi, GUO Zhen-wu, CUI Ying-hai, et al. Observation of Curative Effect of Jinlong Guben Mixture on Treating Asthma in Remission Stage in 113 Cases[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(3): 180-182. DOI： 10.11653/syfj2014030180.

摘要

目的：观察金龙固本合剂治疗支气管哮喘缓解期（宿痰伏肺证）的临床疗效。方法：将223例支气管哮喘缓解期患者随机分为治疗组和对照组，治疗组采用金龙固本合剂口服治疗，对照组不用药物干预，疗程均为120 d，随访期1年。观察两组治疗前后国际哮喘控制测试表（ACT）评分、1秒钟用力呼气量（FEV1）和最大呼气流量（PEF）变化。结果：治疗组可显著改善哮喘缓解期患者的ACT评分、FEV1和PEF，且疗效持久（P<0.01）；治疗组与对照组比较ACT评分和FEV1有显著差异（P < 0.01）。结论：金龙固本合剂治疗支气管哮喘缓解期患者（宿痰伏肺证）具有良好疗效。

Abstract

Objective: To observe the effect of Jinlong Guben mixture on treating asthma in remission stage (Latent phlegm in lung syndrome). Method: One hundred and thirteen patients of asthma on remission stage were randomized to the control group and the treatment group. The treatment group were given Jinlong Guben mixture. The control group were given nothing to be coated

course of treatment were both 120 days and follow-up period were both 360 days. To observe the change of asthma control test (ACT) scores

forced expiratory volume in 1 second(FEV1) and peak expiratory flow(PEF). Result: After treatment

ACT scores

FEV1 and PEF of the treatment group were markedly increased

with statistical significance (P < 0.01)

and can have long-lasting and stable effect. There were significant differences in ACT scores and FEV1 of two groups

with statistical significance (P < 0.01). Conclusion: Jinlong Guben mixture has a good curative effect on treating asthma in remission stage (Latent phlegm in lung syndrome).

关键词

Keywords

references

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

microRNA与支气管哮喘相关性及中药调控机制研究进展

基于网络药理学的射干-麻黄药对治疗支气管哮喘的分子机制探讨

舒康平喘胶囊对哮喘大鼠支气管肺泡灌洗液中细胞因子的影响

定喘汤加减方配合气道吸入糖皮质激素与受体激动剂治疗小儿支气管哮喘

全蝎-蜈蚣药对对哮喘模型大鼠气道炎症及气道重塑的影响